{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:37:12Z","timestamp":1775806632709,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,1]]},"DOI":"10.7759\/cureus.22743","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T16:41:43Z","timestamp":1646152903000},"source":"Crossref","is-referenced-by-count":3,"title":["Adult-Onset Still\u2019s Disease: A Case Report and Review of Current Therapeutic Options"],"prefix":"10.7759","author":[{"given":"Steffi","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vartika","family":"Kesarwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Graber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weishali","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10098","article-title":"A case report on adult-onset Still's disease successfully treated with tocilizumab: a brief review on its safety and efficacy","volume":"12","author":"Nagalli S","year":"2020","unstructured":"Nagalli S, Sharma A, Shankar Kikkeri N, Sherif N. A case report on adult-onset Still's disease successfully treated with tocilizumab: a brief review on its safety and efficacy. Cureus. 2020, 12:e10098. 10.7759\/cureus.10098","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.30.2.121","article-title":"Still's disease in the adult","volume":"30","author":"Bywaters EG","year":"1971","unstructured":"Bywaters EG. Still's disease in the adult. Ann Rheum Dis. 1971, 30:121-33. 10.1136\/ard.30.2.121","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2016.08.003","article-title":"Adult-onset Still's disease: advances in the treatment","volume":"30","author":"Casta\u00f1eda S","year":"2016","unstructured":"Casta\u00f1eda S, Blanco R, Gonz\u00e1lez-Gay MA. Adult-onset Still's disease: advances in the treatment. Best Pract Res Clin Rheumatol. 2016, 30:222-38. 10.1016\/j.berh.2016.08.003","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref4","article-title":"Adult-onset Still's disease: a case report","volume":"58","author":"Sapkota A","year":"2020","unstructured":"Sapkota A, Pokhrel N, Adhikari J, Shrestha B, Yadav YK. Adult-onset Still's disease: a case report. JNMA J Nepal Med Assoc. 2020, 58:115-8.","journal-title":"JNMA J Nepal Med Assoc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i4.886","article-title":"Adult-onset Still's disease evolving with multiple organ failure and death: a case report and review of the literature","volume":"9","author":"Han ZB","year":"2021","unstructured":"Han ZB, Wu J, Liu J, Li HM, Guo K, Sun T. Adult-onset Still's disease evolving with multiple organ failure and death: a case report and review of the literature. World J Clin Cases. 2021, 9:886-97. 10.12998\/wjcc.v9.i4.886","journal-title":"World J Clin Cases"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.54.7.587","article-title":"Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France","volume":"54","author":"Magadur-Joly G","year":"1995","unstructured":"Magadur-Joly G, Billaud E, Barrier JH, Pennec YL, Masson C, Renou P, Prost A. Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis. 1995, 54:587-90. 10.1136\/ard.54.7.587","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.04.004","article-title":"Racial\/Ethnic variations in morbidity and mortality in adult onset Still's disease: an analysis of national dataset","volume":"49","author":"Mehta BY","year":"2019","unstructured":"Mehta BY, Ibrahim S, Briggs W, Efthimiou P. Racial\/Ethnic variations in morbidity and mortality in adult onset Still's disease: an analysis of national dataset. Semin Arthritis Rheum. 2019, 49:469-73. 10.1016\/j.semarthrit.2019.04.004","journal-title":"Semin Arthritis Rheum"},{"key":"ref8","article-title":"Adult Still's disease: a multicenter survey of Japanese patients","volume":"17","author":"Ohta A","year":"1990","unstructured":"Ohta A, Yamaguchi M, Tsunematsu T, et al.. Adult Still's disease: a multicenter survey of Japanese patients. J Rheumatol. 1990, 17:1058-63.","journal-title":"J Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.51.5.683","article-title":"Evaluation of serum ferritin as a marker for adult Still's disease activity","volume":"51","author":"Schwarz-Eywill M","year":"1992","unstructured":"Schwarz-Eywill M, Heilig B, Bauer H, Breitbart A, Pezzutto A. Evaluation of serum ferritin as a marker for adult Still's disease activity. Ann Rheum Dis. 1992, 51:683-5. 10.1136\/ard.51.5.683","journal-title":"Ann Rheum Dis"},{"key":"ref10","article-title":"Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease","volume":"21","author":"Van Reeth C","year":"1994","unstructured":"Van Reeth C, Le Moel G, Lasne Y, Revenant MC, Agneray J, Kahn MF, Bourgeois P. Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease. J Rheumatol. 1994, 21:890-5.","journal-title":"J Rheumatol"},{"key":"ref11","article-title":"Ferritin levels and response to treatment in patients with adult Still's disease","volume":"23","author":"Akritidis N","year":"1996","unstructured":"Akritidis N, Giannakakis I, Giouglis T. Ferritin levels and response to treatment in patients with adult Still's disease. J Rheumatol. 1996, 23:201-2.","journal-title":"J Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(87)90015-1","article-title":"Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure","volume":"17","author":"Reginato AJ","year":"1987","unstructured":"Reginato AJ, Schumacher HR. Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum. 1987, 17:39-57. 10.1016\/0049-0172(87)90015-1","journal-title":"Semin Arthritis Rheum"},{"key":"ref13","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi M","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, et al.. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992, 19:424-30.","journal-title":"J Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780300209","article-title":"Adult-onset Still's disease","volume":"30","author":"Cush JJ","year":"1987","unstructured":"Cush JJ, Medsger TA Jr, Christy WC, Herbert DC, Cooperstein LA. Adult-onset Still's disease. Arthritis Rheum. 1987, 30:186-94. 10.1002\/art.1780300209","journal-title":"Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198005000-00005","article-title":"Acute febrile juvenile rheumatoid arthritis in adults: cause of polyarthritis and fever","volume":"73","author":"Goldman JA","year":"1980","unstructured":"Goldman JA, Beard MR, Casey HL. Acute febrile juvenile rheumatoid arthritis in adults: cause of polyarthritis and fever. South Med J. 1980, 73:555-63. 10.1097\/00007611-198005000-00005","journal-title":"South Med J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a new set of classification criteria for adult-onset Still disease","volume":"81","author":"Fautrel B","year":"2002","unstructured":"Fautrel B, Zing E, Golmard JL, et al.. Proposal for a new set of classification criteria for adult-onset Still disease. Medicine (Baltimore). 2002, 81:194-200. 10.1097\/00005792-200205000-00003","journal-title":"Medicine (Baltimore)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001554","article-title":"Efficacy of anakinra in refractory adult-onset Still's disease. Multicenter study of 41 patients and literature review","volume":"94","author":"Ortiz-Sanju\u00e1n F","year":"2015","unstructured":"Ortiz-Sanju\u00e1n F, Blanco R, Riancho-Zarrabeitia L, et al.. Efficacy of anakinra in refractory adult-onset Still's disease. Multicenter study of 41 patients and literature review. Medicine (Baltimore). 2015, 94:e1554. 10.1097\/MD.0000000000001554","journal-title":"Medicine (Baltimore)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.2.144","article-title":"Methotrexate treatment in patients with adult onset Still's disease--retrospective study of 13 Japanese cases","volume":"56","author":"Fujii T","year":"1997","unstructured":"Fujii T, Akizuki M, Kameda H, et al.. Methotrexate treatment in patients with adult onset Still's disease--retrospective study of 13 Japanese cases. Ann Rheum Dis. 1997, 56:144-8. 10.1136\/ard.56.2.144","journal-title":"Ann Rheum Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2019.1652591","article-title":"Biologics for the treatment of adult-onset Still's disease","volume":"19","author":"Yoo DH","year":"2019","unstructured":"Yoo DH. Biologics for the treatment of adult-onset Still's disease. Expert Opin Biol Ther. 2019, 19:1173-90. 10.1080\/14712598.2019.1652591","journal-title":"Expert Opin Biol Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/art.10231","article-title":"Etanercept in the treatment of adult patients with Still's disease","volume":"46","author":"Husni ME","year":"2002","unstructured":"Husni ME, Maier AL, Mease PJ, Overman SS, Fraser P, Gravallese EM, Weinblatt ME. Etanercept in the treatment of adult patients with Still's disease. Arthritis Rheum. 2002, 46:1171-6. 10.1002\/art.10231","journal-title":"Arthritis Rheum"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000021","article-title":"Adult-onset Still disease. Manifestations, treatment, outcome, and prognostic factors in 57 patients","volume":"93","author":"Gerfaud-Valentin M","year":"2014","unstructured":"Gerfaud-Valentin M, Maucort-Boulch D, Hot A, et al.. Adult-onset Still disease. Manifestations, treatment, outcome, and prognostic factors in 57 patients. Medicine (Baltimore). 2014, 93:91-9. 10.1097\/MD.0000000000000021","journal-title":"Medicine (Baltimore)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.024026","article-title":"Tumour necrosis factor \u03b1 blocking agents in refractory adult Still's disease: an observational study of 20 cases","volume":"64","author":"Fautrel B","year":"2005","unstructured":"Fautrel B, Sibilia J, Mariette X, Combe B. Tumour necrosis factor \u03b1 blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis. 2005, 64:262-6. 10.1136\/ard.2004.024026","journal-title":"Ann Rheum Dis"},{"key":"ref23","article-title":"A case of adult onset Still's disease treated with infliximab","volume":"20","author":"Caramaschi P","year":"2002","unstructured":"Caramaschi P, Biasi D, Carletto A, Bambara LM. A case of adult onset Still's disease treated with infliximab. Clin Exp Rheumatol. 2002, 20:113.","journal-title":"Clin Exp Rheumatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.90003.iii55","article-title":"Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences","volume":"60 Suppl 3","author":"Kraetsch HG","year":"2001","unstructured":"Kraetsch HG, Antoni C, Kalden JR, Manger B. Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences. Ann Rheum Dis. 2001, 60 Suppl 3:iii55-7. 10.1136\/ard.60.90003.iii55","journal-title":"Ann Rheum Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-003-0775-5","article-title":"Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients","volume":"23","author":"Kokkinos A","year":"2004","unstructured":"Kokkinos A, Iliopoulos A, Greka P, Efthymiou A, Katsilambros N, Sfikakis PP. Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol. 2004, 23:45-9. 10.1007\/s10067-003-0775-5","journal-title":"Clin Rheumatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/art.27532","article-title":"Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease","volume":"62","author":"Franchini S","year":"2010","unstructured":"Franchini S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG. Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease. Arthritis Rheum. 2010, 62:2530-5. 10.1002\/art.27532","journal-title":"Arthritis Rheum"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.111549","article-title":"Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study","volume":"39","author":"Nordstr\u00f6m D","year":"2012","unstructured":"Nordstr\u00f6m D, Knight A, Luukkainen R, et al.. Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study. J Rheumatol. 2012, 39:2008-11. 10.3899\/jrheum.111549","journal-title":"J Rheumatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21901","article-title":"Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy","volume":"65","author":"Giampietro C","year":"2013","unstructured":"Giampietro C, Ridene M, Lequerre T, et al.. Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy. Arthritis Care Res (Hoboken). 2013, 65:822-6. 10.1002\/acr.21901","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez350","article-title":"Anakinra in children and adults with Still's disease","volume":"58","author":"Vastert SJ","year":"2019","unstructured":"Vastert SJ, Jamilloux Y, Quartier P, et al.. Anakinra in children and adults with Still's disease. Rheumatology (Oxford). 2019, 58:vi9-vi22. 10.1093\/rheumatology\/kez350","journal-title":"Rheumatology (Oxford)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-2021-9","article-title":"Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts","volume":"21","author":"Colafrancesco S","year":"2019","unstructured":"Colafrancesco S, Manara M, Bortoluzzi A, et al.. Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts. Arthritis Res Ther. 2019, 21:275. 10.1186\/s13075-019-2021-9","journal-title":"Arthritis Res Ther"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213920","article-title":"Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial","volume":"77","author":"Kaneko Y","year":"2018","unstructured":"Kaneko Y, Kameda H, Ikeda K, et al.. Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial. Ann Rheum Dis. 2018, 77:1720-9. 10.1136\/annrheumdis-2018-213920","journal-title":"Ann Rheum Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-011-0569-6","article-title":"Therapeutic response of patients with adult Still's disease to biologic agents: multicenter results in Japan","volume":"22","author":"Suematsu R","year":"2012","unstructured":"Suematsu R, Ohta A, Matsuura E, et al.. Therapeutic response of patients with adult Still's disease to biologic agents: multicenter results in Japan. Mod Rheumatol. 2012, 22:712-9. 10.1007\/s10165-011-0569-6","journal-title":"Mod Rheumatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20319","article-title":"Tocilizumab in refractory adult Still's disease","volume":"63","author":"Pu\u00e9chal X","year":"2011","unstructured":"Pu\u00e9chal X, DeBandt M, Berthelot JM, et al.. Tocilizumab in refractory adult Still's disease. Arthritis Care Res (Hoboken). 2011, 63:155-9. 10.1002\/acr.20319","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205099","article-title":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis","volume":"367","author":"Ruperto N","year":"2012","unstructured":"Ruperto N, Brunner HI, Quartier P, et al.. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012, 367:2396-406. 10.1056\/NEJMoa1205099","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/art.41436","article-title":"Efficacy and safety of canakinumab in patients with systemic juvenile idiopathic arthritis with and without fever at baseline: results from an open-label, active-treatment extension study","volume":"72","author":"Brunner HI","year":"2020","unstructured":"Brunner HI, Quartier P, Alexeeva E, et al.. Efficacy and safety of canakinumab in patients with systemic juvenile idiopathic arthritis with and without fever at baseline: results from an open-label, active-treatment extension study. Arthritis Rheumatol. 2020, 72:2147-58. 10.1002\/art.41436","journal-title":"Arthritis Rheumatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab485","article-title":"Current and emerging biological therapy in adult-onset Still's disease","volume":"60","author":"Ma Y","year":"2021","unstructured":"Ma Y, Meng J, Jia J, et al.. Current and emerging biological therapy in adult-onset Still's disease. Rheumatology (Oxford). 2021, 60:3986-4000. 10.1093\/rheumatology\/keab485","journal-title":"Rheumatology (Oxford)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2012.11.025","article-title":"Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles","volume":"61","author":"Shimizu M","year":"2013","unstructured":"Shimizu M, Nakagishi Y, Yachie A. Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine. 2013, 61:345-8. 10.1016\/j.cyto.2012.11.025","journal-title":"Cytokine"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2016.05.010","article-title":"Cytokine profile in adult-onset Still's disease: comparison with systemic juvenile idiopathic arthritis","volume":"169","author":"Inoue N","year":"2016","unstructured":"Inoue N, Shimizu M, Tsunoda S, Kawano M, Matsumura M, Yachie A. Cytokine profile in adult-onset Still's disease: comparison with systemic juvenile idiopathic arthritis. Clin Immunol. 2016, 169:8-13. 10.1016\/j.clim.2016.05.010","journal-title":"Clin Immunol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-2105-2","article-title":"Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence","volume":"32","author":"de Boysson H","year":"2013","unstructured":"de Boysson H, F\u00e9vrier J, Nicolle A, Auzary C, Geffray L. Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence. Clin Rheumatol. 2013, 32:141-7. 10.1007\/s10067-012-2105-2","journal-title":"Clin Rheumatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216699","article-title":"Tofacitinib in refractory adult-onset Still's disease: 14 cases from a single centre in China","volume":"79","author":"Hu Q","year":"2020","unstructured":"Hu Q, Wang M, Jia J, et al.. Tofacitinib in refractory adult-onset Still's disease: 14 cases from a single centre in China. Ann Rheum Dis. 2020, 79:842-4. 10.1136\/annrheumdis-2019-216699","journal-title":"Ann Rheum Dis"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key414","article-title":"Treatment of refractory adult onset Still's disease with combination anakinra and baricitinib therapy","volume":"58","author":"Ladhari C","year":"2019","unstructured":"Ladhari C, Jorgensen C, Pers YM. Treatment of refractory adult onset Still's disease with combination anakinra and baricitinib therapy. Rheumatology (Oxford). 2019, 58:736-7. 10.1093\/rheumatology\/key414","journal-title":"Rheumatology (Oxford)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212608","article-title":"Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease","volume":"77","author":"Gabay C","year":"2018","unstructured":"Gabay C, Fautrel B, Rech J, et al.. Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease. Ann Rheum Dis. 2018, 77:840-7. 10.1136\/annrheumdis-2017-212608","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/88495-adult-onset-stills-disease-a-case-report-and-review-of-current-therapeutic-options","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:52Z","timestamp":1707507592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/88495-adult-onset-stills-disease-a-case-report-and-review-of-current-therapeutic-options"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.22743","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}